semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight loss Beyond obesity: Novo's SELECT re-defines

[3] Patients should inform their healthcare provider of any thyroid nodules, neck mass, difficulty swallowing, or persistent hoarseness

Harrison S, Tomah S, Suschak J, et al

Were thrilled to introduce this groundbreaking medication, not just for diabetes management but as a powerful ally in achieving your weight loss goals

In Phase 2 substudies, Retatrutide cleared an astonishing amount of excess liver fat

Frequently Asked Questions How long does it usually take to lose 50 pounds with tirzepatide

Main text Modern GLP-1 receptor agonists and co-agonists (GLP-1 medicines) such as liraglutide, dulaglutide semaglutide, and the GLP-1R/glucose dependent insulinotropic polypeptide receptor (GIPR) co-agonist tirzepatide, were initially developed for the treatment of type 2 diabetes (T2D) due to their actions to increase insulin and decrease glucagon secretion and slow gastric emptying through effects on the pancreas and brain